Valbiotis SA

ENXTPA:ALVAL Stock Report

Market Cap: €21.4m

Valbiotis Management

Management criteria checks 4/4

Valbiotis' CEO is Sebastien Peltier, appointed in Mar 2017, has a tenure of 9.25 years. total yearly compensation is €242.00K, comprised of 74.4% salary and 25.6% bonuses, including company stock and options. directly owns 2.74% of the company’s shares, worth €586.38K. The average tenure of the management team and the board of directors is 7.4 years and 7.3 years respectively.

Key information

Sebastien Peltier

Chief executive officer

€242.0k

Total compensation

CEO salary percentage74.38%
CEO tenure9.3yrs
CEO ownership2.7%
Management average tenure7.4yrs
Board average tenure7.3yrs

Recent management updates

Analysis Article • Apr 11

Here's Why We Think Valbiotis SA's (EPA:ALVAL) CEO Compensation Looks Fair

Key Insights Valbiotis to hold its Annual General Meeting on 18th of April CEO Sebastien Peltier's total compensation...

Recent updates

Analysis Article • Nov 19

Does Valbiotis (EPA:ALVAL) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Apr 11

Here's Why We Think Valbiotis SA's (EPA:ALVAL) CEO Compensation Looks Fair

Key Insights Valbiotis to hold its Annual General Meeting on 18th of April CEO Sebastien Peltier's total compensation...
Analysis Article • Jun 20

Is Valbiotis (EPA:ALVAL) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • May 09

Rock star Growth Puts Valbiotis (EPA:ALVAL) In A Position To Use Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analysis Article • May 10

Is Valbiotis (EPA:ALVAL) Using Debt In A Risky Way?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Mar 08

Valbiotis SA (EPA:ALVAL) Is Expected To Breakeven In The Near Future

With the business potentially at an important milestone, we thought we'd take a closer look at Valbiotis SA's...

CEO Compensation Analysis

How has Sebastien Peltier's remuneration changed compared to Valbiotis's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

-€9m

Sep 30 2025n/an/a

-€10m

Jun 30 2025n/an/a

-€11m

Mar 31 2025n/an/a

-€11m

Dec 31 2024€242k€180k

-€10m

Sep 30 2024n/an/a

-€9m

Jun 30 2024n/an/a

-€9m

Mar 31 2024n/an/a

-€8m

Dec 31 2023€301k€180k

-€7m

Sep 30 2023n/an/a

-€8m

Jun 30 2023n/an/a

-€9m

Mar 31 2023n/an/a

-€11m

Dec 31 2022€318k€180k

-€12m

Sep 30 2022n/an/a

-€11m

Jun 30 2022n/an/a

-€10m

Mar 31 2022n/an/a

-€9m

Dec 31 2021€259k€180k

-€9m

Compensation vs Market: Sebastien's total compensation ($USD279.57K) is about average for companies of similar size in the French market ($USD346.30K).

Compensation vs Earnings: Sebastien's compensation has been consistent with company performance over the past year.

CEO

Sebastien Peltier (48 yo)

9.3yrs
Tenure
€242,000
Compensation

Mr. Sebastien Peltier, Ph D., HDR serves as the Chief Executive Officer of Valbiotis SA and is its Co-Founder. Mr. Peltier has been Member of Management Board of Valbiotis SA from March 7, 2017 and is its...

Leadership Team

NamePositionTenureCompensationOwnership
Sebastien Peltier
Co-Founder9.3yrs€242.00k2.74%
€ 586.4k
Stanislas Sordet
CFO & Member of Management Board1.9yrs€262.32k0.042%
€ 9.1k
Sebastien Bessy
COO & Member of the Management Board5yrs€302.00k0.013%
€ 2.7k
Pascal Sirvent
CSO & Member of the Management Board7.8yrs€201.00k0.14%
€ 30.7k
Murielle Cazaubiel
CMO & Member of the Management Board7.4yrs€247.00k0.071%
€ 15.1k
Sebastien Poncet
Member of the Management Board1.4yrsno datano data
Josep Infesta
Head of Global Business Development7.4yrsno datano data
7.4yrs
Average Tenure

Experienced Management: ALVAL's management team is seasoned and experienced (7.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Agnes Tixier
Independent Member of Supervisory Board7.3yrsno datano data
Laurent Levy
Independent Chairman of Supervisory Board9.3yrsno datano data
Nathalie Boisseau
Member of Scientific & Medical Boardno datano datano data
Jean-Marie Bard
Member of Scientific & Medical Boardno datano datano data
Samy Hadjadj
Member of Scientific & Medical Boardno datano datano data
Thierry Maugard
Member of Scientific & Medical Boardno datano datano data
Bruno Guigas
Member of Scientific & Medical Boardno datano datano data
Jean Zetlaoui
Independent Member of Supervisory Board8.7yrsno datano data
Laurent Keiser
Member of Supervisory Boardless than a yearno datano data
Patricia Tranvouez
Member of Supervisory Boardless than a yearno datano data
7.3yrs
Average Tenure
56.5yo
Average Age

Experienced Board: ALVAL's board of directors are considered experienced (7.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/10 19:58
End of Day Share Price 2026/06/10 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Valbiotis SA is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mohamed KaabouniPortzamparc BNP Paribas
Corentin MartyTPICAP Midcap